Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study
- PMID: 33001967
- PMCID: PMC7529306
- DOI: 10.1371/journal.pmed.1003358
Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study
Abstract
Background: Loss of smell and taste are commonly reported symptoms associated with coronavirus disease 2019 (COVID-19); however, the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in people with acute loss of smell and/or taste is unknown. The study aimed to determine the seroprevalence of SARS-CoV-2 antibodies in a community-based population with acute loss of smell and/or taste and to compare the frequency of COVID-19 associated symptoms in participants with and without SARS-CoV-2 antibodies. It also evaluated whether smell or taste loss are indicative of COVID-19 infection.
Methods and findings: Text messages, sent via primary care centers in London, United Kingdom, invited people with loss of smell and/or taste in the preceding month, to participate. Recruitment took place between 23 April 2020 and 14 May 2020. A total of 590 participants enrolled via a web-based platform and responded to questions about loss of smell and taste and other COVID-19-related symptoms. Mean age was 39.4 years (SD ± 12.0) and 69.1% (n = 392) of participants were female. A total of 567 (96.1%) had a telemedicine consultation during which their COVID-19-related symptoms were verified and a lateral flow immunoassay test that detected SARS-CoV-2 immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies was undertaken under medical supervision. A total of 77.6% of 567 participants with acute smell and/or taste loss had SARS-CoV-2 antibodies; of these, 39.8% (n = 175) had neither cough nor fever. New loss of smell was more prevalent in participants with SARS-CoV-2 antibodies, compared with those without antibodies (93.4% versus 78.7%, p < 0.001), whereas taste loss was equally prevalent (90.2% versus 89.0%, p = 0.738). Seropositivity for SARS-CoV-2 was 3 times more likely in participants with smell loss (OR 2.86; 95% CI 1.27-6.36; p < 0.001) compared with those with taste loss. The limitations of this study are the lack of a general population control group, the self-reported nature of the smell and taste changes, and the fact our methodology does not take into account the possibility that a population subset may not seroconvert to develop SARS-CoV-2 antibodies post-COVID-19.
Conclusions: Our findings suggest that recent loss of smell is a highly specific COVID-19 symptom and should be considered more generally in guiding case isolation, testing, and treatment of COVID-19.
Trials registration: ClinicalTrials.gov NCT04377815.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Distorted chemosensory perception and female sex associate with persistent smell and/or taste loss in people with SARS-CoV-2 antibodies: a community based cohort study investigating clinical course and resolution of acute smell and/or taste loss in people with and without SARS-CoV-2 antibodies in London, UK.BMC Infect Dis. 2021 Feb 25;21(1):221. doi: 10.1186/s12879-021-05927-w. BMC Infect Dis. 2021. PMID: 33632171 Free PMC article.
-
Predominance of an altered sense of smell or taste among long-lasting symptoms in patients with mildly symptomatic COVID-19.Rhinology. 2020 Oct 1;58(5):524-525. doi: 10.4193/Rhin20.263. Rhinology. 2020. PMID: 32683438
-
Antibody tests for identification of current and past infection with SARS-CoV-2.Cochrane Database Syst Rev. 2020 Jun 25;6(6):CD013652. doi: 10.1002/14651858.CD013652. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2022 Nov 17;11:CD013652. doi: 10.1002/14651858.CD013652.pub2. PMID: 32584464 Free PMC article. Updated.
-
The Loss of Smell and Taste in the COVID-19 Outbreak: a Tale of Many Countries.Curr Allergy Asthma Rep. 2020 Aug 3;20(10):61. doi: 10.1007/s11882-020-00961-1. Curr Allergy Asthma Rep. 2020. PMID: 32748211 Free PMC article. Review.
-
[Taste and smell loss in patients with COVID-19].Ugeskr Laeger. 2020 Aug 31;182(36):V06200442. Ugeskr Laeger. 2020. PMID: 33000727 Review. Danish.
Cited by
-
Characterizing participants who respond to text, email, phone calls, or postcards in a SARS-CoV-2 prevalence study.BMC Public Health. 2024 Apr 22;24(1):1113. doi: 10.1186/s12889-024-18550-6. BMC Public Health. 2024. PMID: 38649843 Free PMC article.
-
Olfactory and taste disorders in COVID-19: a cross-sectional study in primary health care.Rev Assoc Med Bras (1992). 2024 Jan 22;70(2):e20231018. doi: 10.1590/1806-9282.20231018. eCollection 2024. Rev Assoc Med Bras (1992). 2024. PMID: 38265352 Free PMC article.
-
Role of E3 ubiquitin ligases and deubiquitinating enzymes in SARS-CoV-2 infection.Front Cell Infect Microbiol. 2023 Jun 9;13:1217383. doi: 10.3389/fcimb.2023.1217383. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37360529 Free PMC article. Review.
-
Assessment of the levels of antispike SARS-CoV-2 IgG antibodies and their association with clinical characteristics in cohort of patients in Saudi Arabia.J Family Med Prim Care. 2022 Nov;11(11):7372-7377. doi: 10.4103/jfmpc.jfmpc_1369_22. Epub 2022 Dec 16. J Family Med Prim Care. 2022. PMID: 36993033 Free PMC article.
-
Aberrant olfactory network functional connectivity in people with olfactory dysfunction following COVID-19 infection: an exploratory, observational study.EClinicalMedicine. 2023 Apr;58:101883. doi: 10.1016/j.eclinm.2023.101883. Epub 2023 Mar 2. EClinicalMedicine. 2023. PMID: 36883140 Free PMC article.
References
-
- WHO. Coronavirus disease (COVID-19) pandemic 2020 [Internet]. [cited 2020 9 September]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous